Modulated Imaging's Cuccia to receive research award at ASLMS

David J. Cuccia, Ph.D, chief technology officer and CEO at Modulated Imaging (Irvine, CA), will receive the 2012 Dr. Horace Furumoto Innovations Professional Development Grant at the Annual Conference of the American Society for Laser Medicine and Surgery (ASLMS), to take place April 20–22 in Kissimmee, FL. Dr. Cuccia will use the $5,000 award to study business management science and to advance his professional development as an entrepreneur.

Cuccia earned his Ph.D. in biomedical engineering in 2006 from the University of California, Irvine, with support from a National Science Foundation Graduate Fellowship. His graduate work helped him develop a new technology for quantitative sub-surface imaging of tissues known as spatial frequency domain imaging (SFDI), which employs relatively simple consumer electronics technologies such as digital light projectors and cameras, and turns them into powerful medical instruments that are capable of imaging 5–10 mm beneath the tissue surface. He used this technology to start up Modulated Imaging in December 2006, and now employs six employees. The company is currently focused on developing optical technologies that will impact a number of clinical problems in the diagnostic and therapeutic monitoring sector. Current efforts are directed toward applications that will support burn wound triage, noninvasive identification and assessment of skin cancer, rapid tumor margin delineation, guidance of surgical intervention, identification and monitoring of chronic wounds, and monitoring of chemotherapeutic efficacy.

The annual Dr. Horace Furumoto Innovations Professional Development Grant recognizes and encourages the development of future technology innovators in light energy and related technologies by funding continued professional development. The award was established by Candela, Cynosure, and DEKA to honor Furumoto, who developed the world’s first practical dye laser, the Flashlamp-excited Dye Laser (FEDL) and founded Candela and Cynosure. Furumoto also collaborated with Wellman Laboratories at Massachusetts General Hospital to develop selective photothermolysis, a technology that helped him create laser medical devices for the treatment of birthmarks, kidney stones, and glaucoma.

-----

Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!